Relevant bibliographies by topics / Sexual dysfunction

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Sexual dysfunction'

Author: Grafiati
Published: 4 June 2021
Last updated: 27 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Sexual dysfunction.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Sexual dysfunction"

1

Kim, Jong-Dai. "Diabetes and Sexual Dysfunction." Journal of Korean Diabetes 24, no. 1 (March 31, 2023): 18–23. http://dx.doi.org/10.4093/jkd.2023.24.1.18.

Full text
Abstract:
Type 2 diabetes can produce various sexual dysfunctions in both men and women. Prevalence of sexual dysfunction is 25~75% in type 2 diabetes, which is three times that of the general population. As hyperglycemia persists, atherosclerosis progresses, and macrovascular and microvascular complications can occur. Autonomic neuropathy and hypogonadism are principal causes of various sexual dysfunctions such as erectile dysfunction, retrograde ejaculation, and premature ejaculation in males and loss of libido, vaginal dryness, anorgasmia, and dyspareunia in females. Although erectile dysfunction is reversible in early stages, it is more difficult to control as diabetes and associated autonomic dysfunction and microvascular complications progress. Sexual dysfunction can decrease quality of life in type 2 diabetes patients and is a marker of vascular dysfunction. Sexual dysfunction has prognostic value for cardiovascular events in type 2 diabetes. This illustrates the importance of sexual function evaluation in type 2 diabetes patients.
APA, Harvard, Vancouver, ISO, and other styles
2

Bargiota, Alexandra, Konstantinos Dimitropoulos, Vassilios Tzortzis, and Georgios Koukoulis. "Sexual dysfunction in diabetic women." HORMONES 10, no. 3 (July 15, 2011): 196–206. http://dx.doi.org/10.14310/horm.2002.1309.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cochat Costa Rodrigues, M. C., R. G. Faria, and S. Almeida. "Sexual Dysfunction in Oncology." European Psychiatry 41, S1 (April 2017): S282. http://dx.doi.org/10.1016/j.eurpsy.2017.02.130.

Full text
Abstract:
IntroductionSexual dysfunction is a common consequence of cancer treatment that affects at least half of men and women treated for pelvic tumors and more than one quarter of individuals with other malignancies.Objectives/aimsIdentification of the main sexual dysfunctions related to cancer treatments. Awareness to the importance of addressing sexuality to cancer patients, identifying the main reasons why healthcare providers usually do not.MethodsLiterature review concerning researched articles published in Pubmed/Medline as well as related bibliography.ResultsMost sexual problems are not caused by the cancer itself, but by toxicities of cancer treatment. Damage during cancer treatment to pelvic nerves, blood vessels and organ structures leads to the highest rates of sexual dysfunction. The most common sexual dysfunction in men under cancer treatment is the loss of desire for sex and erectile dysfunction. In women, the most common sexual dysfunctions are vaginal dryness, dyspareunia and loss of sexual desire, usually accompanied by difficulties in both the arousal and orgasm phases. According to literature, there are many cancer patients who would like to be informed and advised by their healthcare providers about the consequences of cancer treatment on their sexual health. Unfortunately, this rarely happens.ConclusionsThis work intends to publicize current existing information on sexual dysfunction in oncology, focusing on the prevalence, etiology and clinical presentation. The authors also intend to promote communication about sexual function and possible sexual dysfunctions resulting from cancer treatments.Disclosure of interestThe authors have not supplied their declaration of competing interest.
APA, Harvard, Vancouver, ISO, and other styles
4

Hatzimouratidis, Konstantinos. "Epidemiology of Male Sexual Dysfunction." American Journal of Men's Health 1, no. 2 (May 14, 2007): 103–25. http://dx.doi.org/10.1177/1557988306298006.

Full text
Abstract:
Male sexual dysfunction includes erectile dysfunction (ED), ejaculation disorders, orgasmic dysfunctions, and disorders of sexual interest/desire. Although current epidemiologic research supports the high prevalence of ED worldwide, incidence data are limited. Furthermore, prevalence data on other male sexual dysfunctions are also limited whereas incidence data are lacking. These epidemiologic data vary widely due to the different definitions used, the method of sampling, and the unknown value of the instruments used to assess sexual dysfunction. Many of the epidemiologic studies are old and associated with poor methodology. Although risk factors for ED are well described, there are almost no data for risk factors in other sexual dysfunctions. The impact of modification of risk factors in sexual dysfunctions is extremely interesting. To provide evidence-based data, there is an urgent need for new, properly designed epidemiological research.
APA, Harvard, Vancouver, ISO, and other styles
5

Nobre, Pedro J., and José Pinto‐Gouveia. "Dysfunctional sexual beliefs as vulnerability factors for sexual dysfunction." Journal of Sex Research 43, no. 1 (February 2006): 68–75. http://dx.doi.org/10.1080/00224490609552300.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dčttore, Davide, Helen Casale, and Antonella Montano. "Fattori cognitivi ed emotivi legati allo sviluppo del Disturbo Maschile dell'Erezione." RIVISTA DI SESSUOLOGIA CLINICA, no. 2 (December 2009): 21–48. http://dx.doi.org/10.3280/rsc2009-002002.

Full text
Abstract:
- The aim of the present research is to investigate the relation between beliefs about sexuality, cognitive factors, emotional factors, and erectile dysfunction. 15 adult males (aged 29-66) with psychogenic erectile dysfunction were compared with 15 adult non-dysfunctional males (aged 29-71) with regard to their beliefs in sexual myths, their expectations, and their emotions during sexual activity. Erectile dysfunction was assessed by SDI (Sexual Dysfunction Interview) and measured by the International Index of Erectile Function (IIEF). Beliefs about sexuality, as well as cognitive and emotional factors of sexual function were measured respectively by Sexual Dysfunctional Beliefs Questionnaire (SDBQ) and Sexual Modes Questionnaire (SMQ). Results show in dysfunctional group an higher level of dysfunctional or irrational beliefs, of negative emotions and automatic thoughts during sexual activity. Beyond this, our data show high correlations between automatic thoughts and sexual functioning, and between worry and sexual functioning These results emphasize the role of cognitive-emotional processes on erectile dysfunction development and maintenance.
APA, Harvard, Vancouver, ISO, and other styles
7

Bawany, Muhammad Adnan, Abdul Aziz Sahito, Falak Naz, Adnan Ali Khahro, Rabail Bohio, Farrukh Bohio, and Syeda Fiza Nasir. "SEXUAL DYSFUNCTION;." Professional Medical Journal 24, no. 06 (June 5, 2017): 888–92. http://dx.doi.org/10.29309/tpmj/2017.24.06.1190.

Full text
Abstract:
Objectives: To determine the frequency of sexual dysfunction in the patientssuffering from chronic liver disease. Period: 1 year from June 2013 to May 2014. Study Design:An observational study. Setting: Asian Institute of Medical Sciences. Methodology: 150 casesof chronic liver disease including patients of both genders at Asian Institute of medical scienceswho had suggestive history and signs /symptoms of sexual dysfunction. Results: Study found51.3% of total patients were suffering with sexual dysfunction. Out of all participating females,52.2% were affected and among the total male patients 51% males were suffering from sexualdysfunction. Hepatitis C virus (HCV) and Hepatitis B virus (HBV) were positive in 76.7% and11.3%, respectively. Conclusion: Sexual dysfunction is a common complication in the patientssuffering from chronic liver disease.
APA, Harvard, Vancouver, ISO, and other styles
8

Lackamp, Jeanne M. "Sexual Dysfunction." Journal of Clinical Psychiatry 71, no. 01 (January 15, 2010): 94. http://dx.doi.org/10.4088/jcp.09bk05447.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Davies, Sonia. "Sexual dysfunction." Nursing Standard 23, no. 50 (August 19, 2009): 58. http://dx.doi.org/10.7748/ns2009.08.23.50.58.c7215.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Beck, William W. "Sexual Dysfunction." Postgraduate Obstetrics & Gynecology 16, no. 10 (May 1996): 1–5. http://dx.doi.org/10.1097/00256406-199616100-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Sexual dysfunction"

1

Louizos, Connie Celest. "Sexual Inhibition and Sexual Excitation in Erectile Dysfunction." Thesis, The University of Sydney, 2016. http://hdl.handle.net/2123/15843.

Full text
Abstract:
Erectile dysfunction (ED) is a common problem with many aetiologies. The development of phosphodiesterase type 5 inhibitors (PDE5Is) has offered a highly efficacious therapeutic approach to the treatment of ED. However, a significant number of men fail to respond to medication, and others discontinue its use despite good therapeutic responses. Little is known about the determinants of low PDE5I efficacy or compliance. It is recognised that adequate sexual arousal is necessary in order for PDE5Is to have an effect, but arousability is rarely assessed during the routine therapeutic workup. It is therefore possible that unidentified low arousability contributes to therapeutic failure. The Dual Control Model of Sexual Response offers a theoretical framework for the investigation of sexual excitation and inhibition (which may impact on arousability) that can be undertaken using its associated questionnaire, the sexual excitation/sexual inhibition questionnaire (SIS/SES). The purpose of the studies reported in this thesis was to evaluate how the propensities of sexual excitation and inhibition relate to ED sufferers response to PDE5I therapy. The studies focused on men being treated by general practitioners for apparent psychogenic ED. Four studies were conducted. In the first study, the aim was to investigate whether individual differences in the propensity for sexual inhibition and excitation measured using the SIS/SES questionnaire predicted responses to PDE5Is. The study was based on the hypothesis that men with lower arousability, operationalized as low excitation, would be less responsive to PDE5I then men with higher excitation. Men aged 18 and older (N = 100) who were prescribed PDE5Is for the first time were recruited into the study and assessed at baseline and 3 months as part of their normal course of care. The severity of ED was assessed using the erection function (EF) scale of the International Index of Erectile Function (IIEF), and sexual inhibition and excitation were measured using the SIS/SES questionnaire. The results of this study showed that higher SES and IIEF-EF scores at the beginning of therapy were predictive of a larger improvement in IIEF-EF score in response to therapy. Sexual inhibition scores were not predictive of changes in IIEF-EF scores. The findings suggest that an individual’s propensity for sexual excitation influences their response to PDE5I therapy. In the clinical setting, evaluation of the propensity for sexual excitation may help practitioners determine which of the treatment options available is most likely to have the best result. It is possible that men with lower SES scores should receive PDE5Is at the highest possible dose. The second study evaluated whether the ongoing failure of PDE5I therapy to improve erectile function had an adverse impact on sexual excitation and/or inhibition, and therefore decreased the likelihood of a successful response in the future. Established PDE5I users completed the SIS/SES questionnaire at recruitment and three months later. On the basis of IIEF scores at recruitment, subjects were divided into two groups according to the severity of their ED - mildly affected (M) and mild – moderately affected (MM). SES scores were significantly lower, and SIS1 scores significantly higher in Group MM at recruitment and at three months (P < 0.001). In Group M, SES scores increased (P < 0.005) and SIS1 (P < 0.001) and SIS2 (P = 0.01) scores decreased over the three months of the study. In Group MM, SES scores decreased while SIS1 scores increased over the study period (P < 0.001). The results for Group M showed that men whose EF scores increased were more likely to experience increased SIS2 and decreased SES scores. Analysis of the results using multiple linear regression showed that SIS/SES variables were of little value in predicting erectile function (EF) at recruitment, or change in EF during the study period. This was an unexpected finding, because previous studies have consistently shown a link between SIS1 and IIEF-EF scores. It is possible that sexual excitation and inhibition, although fundamentally traits, may also be influenced by the current state of the patient. The findings of this study suggest that the severity of ED in non-responders influences how the state component of measured excitation and inhibition changes over time, with more severely affected patients experiencing changes that decrease the likelihood of a successful response to PDE5Is in the future. The third study built on the finding reported by Lykins et al (2012) that couples’ similarities in sexual excitation and inhibition predict sexual function in men who were not experiencing clinical ED. The aim was to investigate whether the degree of between-partner similarity or dissimilarity in the propensity for sexual inhibition and excitation in heterosexual couples (N = 189) predicted the severity of ED in patients who had sought treatment for ED. The severity of ED was assessed using the erection function domain of the International Index of Erectile Function (IIEF-EF), and sexual inhibition and excitation were measured, in both men and women, using the SIS/SES questionnaire. Regression analyses showed that men (ß = -0.21, t = -2.9, P = 0.004) and women’s SIS1 scores (ß = -0.42, t = -6.2, P = 0.001), and couple similarity in SES scores (ß = 0.19, t = 3.0, P = 0.002), were significant predictors of IIEF-EF score, and that couple similarity in SIS1 scores negatively predicts IIEF-EF, meaning better erectile function. In other words, lower SIS1 scores at baseline predicted a higher erectile function score on the IIEF-EF. In the fourth study, the aim was to determine whether sexual excitation and inhibition influenced patients’ expectations of the therapeutic response to PDE5Is, and whether those expectations were predictive of the actual therapeutic response. A questionnaire was developed and used to collect data on expectations in eighty men commencing PDE5I therapy, and after three and six months of treatment. At the same time, subjects completed the IIEF, SIS/SES and Beck’s Depression Inventory (BDI). SIS/SES scores were not predictive of scores of any items on the expectations questionnaire, nor was there any evidence of an effect on expectations on changes in IIEF or BDI scores. Although changes in IIEF and BDI scores from recruitment to 3 months were indicative of improved sexual function and less depression, scores on items on the expectations scale decreased, suggesting that expectations were not being met. The items for which scores decreased were the expectation to be prescribed a drug, that the drug would restore the sexual function to normal, would work within 30 minutes of administration, improve patients confidence to engage in sexual activity, and that the medication was the best treatment for ED across the three data collection points. The findings of the study suggested that the education of patients about how PDE5Is should be used was sub- optimal. The findings of these studies suggest that the measurement of sexual inhibition and excitation can provide some information that may be of use in planning PDE5I therapy. Specifically, the capacity to predict the response to medication may enable clinicians to create more realistic expectations in their patients, and therefore decrease the risk of dissatisfaction and discontinuation. If men with low arousability can be identified, it may be possible to implement counselling strategies to address the problem and improve the likelihood of therapeutic success. This concept can be extended to partners, given that these studies have shown that partner similarities predict some of the therapeutic response to PDE5Is.
APA, Harvard, Vancouver, ISO, and other styles
2

Baldwin, David Stewart. "Antidepressant drugs and sexual dysfunction." Thesis, University of Southampton, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.403830.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mitchell, Kirstin Rebecca. "Sexual dysfunction : conceptual and measurement issues." Thesis, London School of Hygiene and Tropical Medicine (University of London), 2008. http://researchonline.lshtm.ac.uk/682371/.

Full text
Abstract:
Despite a standard classification and array of self-report questionnaires, there is little consensus about how to define and measure sexual dysfunction. Recently the debate has been influenced by the pharmaceutical industry, leading to an increasingly medicalised view of sexual difficulties. The aim of this thesis was to explore the meaning of sexual (dys)function to those who have and have not experienced sexual difficulties; and to use these meanings to create a conceptual model and population prevalence measure of sexual dysfunction for use in UK community surveys. Thirty-two semi-structured interviews were conducted with individuals recruited from a GP practice, an HIV/AIDS Charity and a Sexual Problems Clinic. The data were analysed using principles derived from Grounded Theory. Variation in individual meaning was expressed in terms of three distinct versions of functional sex - the erotic, the interpersonal and the mechanistic - which framed the purpose of sexual activity, the criteria determining ideal sex, and threats to this ideal. The data highlighted several coping strategies that individuals adopted when their lived reality failed to match their ideal: changing circumstances to fit goals, for instance by seeking a medical cure; changing goals to fit circumstances, for instance by lowering expectations; And living with the gap between ideal and actual experience, for instance by avoiding the problem. Choice of strategy and the likelihood of successful adjustment were influenced by the severity of the problem, causal attributions made about the problem, and the partnership context. Thirty-one potential components of a functioning sex life were identified from the data. Using evidence both from the literature and from this study, 12 of these components were selected for inclusion in a conceptual model of sexual function. This model was transformed into a 19-item draft prevalence measure of sexual dysfunction ready for psychometric testing and validation.
APA, Harvard, Vancouver, ISO, and other styles
4

Zhang, Xiang Rong. "Mechanisms of antipsychotic-induced male sexual dysfunction." Thesis, Queen's University Belfast, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.517534.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Itkin, Natalie. "Treating Sexual Dysfunction in Orthodox Jewish Couples." Thesis, Alliant International University, 2014. http://pqdtopen.proquest.com/#viewpdf?dispub=3624617.

Full text
Abstract:

Sexual dysfunction is a major clinical and social issue. There has been a lack of research literature exploring the treatment implications involved in conducting sex therapy with Orthodox Jewish couples. Many standard sex therapy treatment interventions are incongruent with the religious beliefs held by Orthodox Jewish individuals regarding what they consider to be sexually appropriate practices. In order to increase the probability of Orthodox clients getting the treatment they need, it is crucial for mental health clinicians to demonstrate a high-level of understanding, awareness, and sensitivity toward their clients' religious beliefs. By fostering a sense of appreciation and understanding of Orthodox Jewish sexual practices, the clinician can then gain the ability to increase their clients' level of trust, safety, comfort, and willingness to participate in the treatment process. This doctoral project explored the issues surrounding the provision of sex therapy to Orthodox Jewish couples, and aimed to bridge the gap between the research literature and clinical practice. The purpose of this project was to increase the level of awareness of mental health professionals regarding how Orthodox Jewish religious beliefs influence views about sexuality, understand the treatment implications that arise during sex therapy with Orthodox couples, and methods of effectively modifying standard sex therapy interventions by incorporating Jewish laws into the therapeutic process. The author also incorporated a summary of the clinical findings obtained from interviews conducted with four expert field consultants who have worked with Orthodox Jewish couples in their practices.

APA, Harvard, Vancouver, ISO, and other styles
6

Braymam, Melanie. "Sexual Dysfunction: Providers’ Willingness to Ask LGBQ Veterans About their Sexual Functioning." Antioch University / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=antioch1555249670122064.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sahay, Rashmi. "Female Sexual Dysfunction in women with Multiple Sclerosis." University of Cincinnati / OhioLINK, 2010. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1276947276.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Cantor, James M. "Reversal of fluoxetine-induced sexual dysfunction in male rats." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp04/nq64531.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Yuen, Hang-yuk. "A study of sexual dysfunction in female breast cancer patients /." Hong Kong : University of Hong Kong, 1996. http://sunzi.lib.hku.hk/hkuto/record.jsp?B19470794.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nunes, Luciana Vargas Alves [UNIFESP]. "A acurácia da Escala de Experiência Sexual do Arizona (ASEX) para identificar disfunção sexual em pacientes do espectro da esquizofrenia." Universidade Federal de São Paulo (UNIFESP), 2009. http://repositorio.unifesp.br/handle/11600/8805.

Full text
Abstract:
Made available in DSpace on 2015-07-22T20:49:11Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-02-27. Added 1 bitstream(s) on 2015-08-11T03:25:33Z : No. of bitstreams: 1 Publico-008.pdf: 1147299 bytes, checksum: c53fe718c40d4278be6155456942dfbe (MD5)
Contexto: a disfunção sexual é frequente entre pacientes com esquizofrenia, sendo relatada como um dos mais incômodos efeitos adversos dos antipsicóticos e esta diretamente relacionada com adesão ao tratamento. Objetivo: a) avaliar a frequência da disfunção sexual em uma amostra de pacientes do espectro da esquizofrenia em tratamento com antipsicóticos; b) investigar 0 efeito dos diferentes antipsicóticos na função sexual; e c) avaliar a acurácia da Escala de Experiência Sexual do Arizona (AS EX) para identificar disfunção sexual. Método: pacientes ambulatoriais com esquizofrenia ou transtorno esquizoafetivo foram entrevistados através de questionários: ASEX e Escala Dickson-Glazer (DGSFi) para avaliação do funcionamento sexual, em uma única entrevista. Resultados: 137 pacientes foram entrevistados. A sensibilidade e especificidade da ASEX em relação a DGSFi foram: 80.8% ( 95% IC= 70.0%-88.5%) e 88.1 % (95% IC=76.5%-94.7%), e a taxa de classificação incorreta foi 9.5%. A curva ROC comparando a pontuação da ASEX e DGSFi revelou valor de 0.93 (IC=0.879¬0.970) com 0 ponto de corte da ASEX encontrando sendo 14/15. A disfunção sexual foi mais alta entre as mulheres (79.2%) do que nos homens (33.3%) (X2=27.41, gl=1, p<0.001). Conclusão: pacientes em tratamento com antipsicóticos mostraram alta frequência de queixas sexuais e ASEX provou ser um instrumento eficaz para identificar disfunção sexual em amostra de pacientes ambulatoriais do espectro da esquizofrenia. Mulheres mostraram frequência mais alta de disfunção, e desejo sexual e habilidade para alcançar orgasmo foram áreas mais afetadas. 0 uso de antipsicóticos, principal mente 0 uso de combinações, foi associado com piora do funcionamento sexual..
Background: sexual dysfunction is frequent in patients with schizophrenia, it is reported as one of the most distressing antipsychotic’s adverse effects and it is directly related to treatment compliance. Objective: a) to assess the frequency of sexual dysfunction in a sample of outpatients with schizophrenia and schizoaffective disorder under antipsychotic therapy; b) to investigate the effect of different antipsychotics on sexual function; and c) to evaluate the accuracy of the Arizona Sexual Experience Scale (ASEX) to identify sexual dysfunction. Method: Outpatients with schizophrenia or schizoaffective disorder were asked to fulfill both the ASEX and the Dickson Glazer Scale for the Assessment of Sexual Functioning Inventory (DGSFi) at a single interview. Results: 137 patients were interwied. The sensitivity and specificity of the ASEX in relation to DGSFi were: 80.8%, (95% CI= 70.0%-88.5%) and 88.1% (95% CI= 76.5%-94.7%), and the misclassification rate was 9.5%. The ROC curve comparing the ASEX and the DGSFi scores revealed a value of 0.93 (CI= 0.879-0.970), with the optimum cut-off point of ASEX being 14/15. Sexual dysfunction measured was higher in females (79.2%) than in males (33.3%) (2 = 27.41, d.f.=1, p<0.001). Discussion: Patients under antipsychotic treatment showed a high level of sexual complaints, and the ASEX proved to be an accurate instrument to identify sexual dysfunction in an outpatient sample of patients with schizophrenia spectrum. Females showed a higher frequency of sexual dysfunctions and sexual drive and ability to reach orgasm were the most affected areas. The use of antipsychotics, especially the combinations, was more likely to impair sexual functioning.
TEDE
BV UNIFESP: Teses e dissertações
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Sexual dysfunction"

1

Richard, Balon, ed. Sexual dysfunction. Basel: Karger, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

International Consultation on Sexual Dysfunctions (2nd : 2003 : Paris, France), ed. Clinical manual of sexual medicine: Sexual dysfunctions in men. [Paris, France?]: Health Publications Ltd., 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Minhas, Suks, and John Mulhall, eds. Male Sexual Dysfunction. Chichester, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781118746509.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Dx/Rx: Sexual dysfunction. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zaslau, Stanley. Dx/Rx: Sexual dysfunction. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lue, Tom F., ed. Atlas of Male Sexual Dysfunction. London: Current Medicine Group, 2004. http://dx.doi.org/10.1007/978-1-4613-1087-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Costantini, Elisabetta, Donata Villari, and Maria Teresa Filocamo, eds. Female Sexual Function and Dysfunction. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-41716-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hellstrom, Wayne J. G., ed. Male Infertility and Sexual Dysfunction. New York, NY: Springer New York, 1997. http://dx.doi.org/10.1007/978-1-4612-1848-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

G, Hellstrom Wayne J., ed. Male infertility and sexual dysfunction. New York: Springer, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Broderick, Gregory A., ed. Oral Pharmacotherapy for Male Sexual Dysfunction. Totowa, NJ: Humana Press, 2005. http://dx.doi.org/10.1385/1592598714.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Sexual dysfunction"

1

Wylie, Kevan. "Erectile Dysfunction." In Sexual Dysfunction, 33–49. Basel: KARGER, 2008. http://dx.doi.org/10.1159/000126623.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Marhenke, Tristan. "Sexual Dysfunction." In Sexual Disorders, 3–27. Wiesbaden: Springer Fachmedien Wiesbaden, 2022. http://dx.doi.org/10.1007/978-3-658-35721-4_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pargeon, Kimberly, Karen Anderson, and William J. Weiner. "Sexual Dysfunction." In Parkinson's Disease, 296–303. Oxford, UK: Blackwell Publishing Ltd., 2011. http://dx.doi.org/10.1002/9781444397970.ch27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

LoPiccolo, Joseph. "Sexual Dysfunction." In International Handbook of Behavior Modification and Therapy, 547–64. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4613-0523-1_26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wylie, Kevan R. "Sexual Dysfunction." In Dewhurst's Textbook of Obstetrics & Gynaecology, 954–66. Chichester, UK: John Wiley & Sons, Ltd, 2018. http://dx.doi.org/10.1002/9781119211457.ch66.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Williams, Nina, and Sandra L. Leiblum. "Sexual Dysfunction." In Handbook of Women’s Sexual and Reproductive Health, 303–28. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/978-1-4615-0689-8_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rogers, Rebecca G., and Teresita McCarty. "Sexual Dysfunction." In Encyclopedia of Women’s Health, 1183–85. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-0-306-48113-0_395.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Koehler, Jean D. "Sexual Dysfunction." In Primary Care in Obstetrics and Gynecology, 485–524. New York, NY: Springer New York, 1998. http://dx.doi.org/10.1007/978-1-4757-2943-6_34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hall, Kathryn S. K., and Sandra R. Leiblum. "Sexual Dysfunction." In Handbook of Outpatient Treatment of Adults, 235–69. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4899-0894-0_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Domoney, Claudine. "Sexual Dysfunction." In Dewhurst's Textbook of Obstetrics & Gynaecology, 783–97. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781119979449.ch59.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Sexual dysfunction"

1

Chung, Gabriel, Darah Fontes da Silva Assunção, Lohana Santana Almeida da Silva, Luiza Ramos de Freitas, Marcelle Sanjuan Ganem Prado, Matheus Kohama Kormanski, Paulo Henrique Maia de Freitas, Rônney Pinto Lopes, Rosa Maria Nascimento Marcusso, and Rubens José Gagliardi. "Prevalence of sexual dysfunction in men with ischemic stroke: a cross-sectional study." In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.726.

Full text
Abstract:
Introduction: Stroke is the leading cause of disability worldwide. Late complications, such as sexual dysfunction, have a direct impact on psychological and emotional aspects and directly affect the quality of life of these patients. Objectives and methods: We present a cross-sectional study that aimed to determine the prevalence of sexual dysfunction in patients with ischemic stroke followed in the neurovascular outpatient clinic of a tertiary hospital in São Paulo, Brazil, using the Male Sexual Quotient (MSQ) questionnaire. The MSQ can range from 0-100 points. Higher values indicate better sexual performance/satisfaction and a score of 60 points or less was considered as having sexual dysfunction. Casuistics and results: Fifty eight questionnaires were analyzed and classified according to the MSQ score. Mean age was 60 years and median MSQ score was 64 points. Of the interviewees, 24.14% had their sexual performance classified as poor-null, 17.24% of patients had poorunfavorable sexual performance, 6.90% as unfavorable-regular; regulargood and good-great sexual performance were equally found in 25.86% of the subjects. Discussion and conclusion: In this study, almost half of post-stroke men have sexual dysfunction according to MSQ, indicating a high impact of such a condition in the quality of life of our patients due to its prevalence. Thus, the health professional dealing with post-stroke patients must be aware and prepared to help patients in coping with sexual dysfunctions.
APA, Harvard, Vancouver, ISO, and other styles
2

Prado, Marcelle Sanjuan Ganem, Darah Fontes da Silva Assunção, Luiza Ramos de Freitas, Paulo Henrique Maia de Freitas, Lohana Santana Almeida da Silva, Tamara Melissa Zavadzki Albuquerque, Natalia Trombini Mendes, Rônney Pinto Lopes, Rosa Maria Nascimento Marcusso, and Rubens José Gagliardi. "Prevalence of sexual dysfunction in women with ischemic stroke: a cross-sectional study." In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.716.

Full text
Abstract:
Introduction: Stroke is characterized by the acute onset of one or more neurologic deficits that persist for at least 24 hours, and is the result of a vascular disorder in a defined territory, being the leading cause of disability. Late complications, such as sexual dysfunction, have a direct impact on psychological and emotional aspects and directly affect the quality of life of these patients. Objectives and methods: Cross-sectional study that aimed to determine the prevalence of sexual dysfunction in patients with ischemic stroke followed in the neurovascular outpatient clinic of a tertiary hospital in São Paulo, Brazil, using the Female Sexual Quotient (FSQ) questionnaire. The FSQ can range from 0-100 points. Higher values indicate better sexual performance/satisfaction and a score of 60 points or less was considered as having sexual dysfunction. Casuistics and results: Sixty-five questionnaires were analyzed and classified according to the FSQ score. Mean age was 52 years and median FSQ score was 54 points. Of the interviewees, 30.7% had their sexual performance classified as poor-null, 13.85% of patients had poor-unfavorable sexual performance, 15.38% as unfavorable-regular. Regular-good and good-great sexual performance were found in 21.54% and 18.46%, respectively. Discussion: In this study, only 40% of post-stroke women have regular-good and good-great sexual performance. The impact of the stroke on the sexual life of these patients is high, because most of the interviewees had sexual dysfunction according to FSQ. Conclusion: The health professional must be aware of the non-motor sequelae caused by the stroke and be prepared to help these patients in coping with sexual dysfunctions.
APA, Harvard, Vancouver, ISO, and other styles
3

Nguanboonmak, Apirak, and Marut Yanaranop. "Sexual dysfunction in gynecologic cancer survivors." In The 7th Biennial Meeting of Asian Society of Gynecologic Oncology. Korea: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology, 2021. http://dx.doi.org/10.3802/jgo.2021.32.s1.m19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Buttros, Daniel, Caroline Nakano Vitorino, Heloisa Maria de Luca Vespoli, Rafaela Caroline de Souza, and Eliana Aguiar Petri Nahás. "Negative impact of adjuvant endocrine therapy on sexual function in breast cancer survivors." In Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1037.

Full text
Abstract:
Objective: The objectives of this study were to evaluate the sexual function of postmenopausal breast cancer survivors compared with women without breast cancer and assess the impact of adjuvant breast cancer treatment on sexual function. Methodology: A cross-sectional study was conducted on 178 breast cancer survivors, stages I–III, age 45–70 years, amenorrhea for ³12 months, and sexually active, compared with 178 women with the same inclusion criteria, but without breast cancer. The groups were paired by age and menopause time, ratio 1:1. Sexual function was assessed using the Female Sexual Function Index (FSFI), consisting of six domains (desire, arousal, lubrication, orgasm, satisfaction, and pain), in which a total score ≤ 26.5 indicates sexual dysfunction. For statistical analysis, the Student’s t-test, the chi-square test, and logistic regression (odds ratio (OR)) were used. Results: Women with breast cancer had poorer sexual function in the desire domain (p=0.002). There were no significant differences between groups in the other FSFI domains and in the total score (p>0.05). Breast cancer survivors had a higher occurrence of sexual dysfunction (64.6% with a total score ≤26.5) when compared to the control group (51.6%) (p=0.010). Risk analysis adjusted for age and time since menopause showed a higher risk of sexual dysfunction in breast cancer survivors than women without cancer (OR 1.98, 95%CI 1.29– 2.96, p=0.007). Among breast cancer survivors, the use of endocrine therapy was associated with a higher risk of sexual dysfunction (OR 3.46, 95%CI 1.59–7.51, p=0.002). Conclusion: Postmenopausal breast cancer survivors had a higher risk of sexual dysfunction when compared with women without breast cancer, impacted by the use of endocrine therapy for the treatment of breast cancer.
APA, Harvard, Vancouver, ISO, and other styles
5

Abdallah, Haifa Hadj, Nadia Bouzid, Souha Massoudi, Sabrine Tbessi, Asma Falfoul, Ons Bettaieb, Amal Chamsi, Imen Abdellatif, Samia Kanoun, and Sameh Tebra. "1229 Sexual dysfunction among cervical cancer survivors." In ESGO 2024 Congress Abstracts. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/ijgc-2024-esgo.956.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Borges, Matheus Araújo, Isabel Cristina Borges de Menezes, Isabela Garcia Bessa, Gabrielly de Souza Correia, Maria Clara Rocha Elias Dib, Rafaela Joy Falcão, and Leslivan Ubiratan Moraes. "Sexual dysfunction associated with neurological disorders in men aged 19 to 44 years." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.164.

Full text
Abstract:
Introduction: Male sexual dysfunction (DSM) is characterized by changes in qualitative or quantitative sexual capacity, manifested by changes in ejaculation, erection, and/or orgasm, in addition to the presence of pain or discomfort in sexual relations, and the main one of these is erectile dysfunction (ED). Objective: Review the literature on sexual dysfunction caused by neurological disorders, in men aged 19 to 44 years. Methodology: This is a narrative literature review. The collection of information about the theme was carried out through a search for scientific articles in the PubMed databases. The descriptions used in the search were “sexual dysfunction AND neurological disorders in men”, articles published in the last 5 years were considered. Results: Several neurological diseases with a very high correlation with DSM were found, such as: multiple sclerosis, ED being the main problem reported by patients, depression and its respective treatment, epilepsy, mainly associated with anxiety and depression, Parkinson’s disease, spinal cord injury, spina bifida, stroke and traumatic brain injury, especially when associated with diabetic neuropathy. Conclusion: DS is a very frequent problem in neurological diseases, therefore, there is a need for this theme not to be neglected by health professionals, emphasizing the importance of multidisciplinary treatment. Mersh Terms: Impotence, Male Sexual Impotence, Nervous System Disease.
APA, Harvard, Vancouver, ISO, and other styles
7

Yaprak Cetin, S., Ayse Ayan, and Alime Buyuk Gonen. "AB1396-HPR SEXUAL SATISFACTION AND SEXUAL DYSFUNCTION IN PARTNER OF PATIENTS WITH ANKYLOSING SPONDYLITIS." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.6779.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hermankova, B., M. Spiritovic, H. Smucrova, S. Oreska, H. Storkanova, K. Pavelka, J. Vencovsky, L. Senolt, R. Becvar, and M. Tomcik. "SAT0483 Female sexual dysfunction in patients with systemic sclerosis." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.7454.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Goldfarb, S., M. Dickler, M. Fruscione, L. Sit, R. Jia, J. Kaplan, T. Barz, T. Atkinson, C. Hudis, and E. Basch. "Burden of Sexual Dysfunction in Women with Breast Cancer." In Abstracts: Thirty-Second Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 10‐13, 2009; San Antonio, TX. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-09-1056.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Carvalho, Mayara M. P., Ana Luiza L. Sousa, Marcia F. Veloso, and Ruffo Freitas Junior. "SEXUAL DYSFUNCTION AMONG WOMEN WITH BREAST CANCER DIAGNOSTIC: DESCRIPTIVE STUDY." In Brazilian Breast Cancer Symposium. v29s1, 2019. http://dx.doi.org/10.29289/259453942019v29s1ep06.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Sexual dysfunction"

1

Clark, Robert D. Heart Rate Variability in Male Sexual Arousal and Erectile Dysfunction. Fort Belvoir, VA: Defense Technical Information Center, January 2007. http://dx.doi.org/10.21236/ad1013961.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Yang, Fang, Liang Dong, Xiaojin Zhang, Junjun Li, Kun Tan, Yulin Li, and Xujun Yu. Vasectomy and male sexual dysfunction risk: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2020. http://dx.doi.org/10.37766/inplasy2020.8.0014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Grill, Raymond J. The Blood-Testis Barrier and Male Sexual Dysfunction following Spinal Cord Injury. Fort Belvoir, VA: Defense Technical Information Center, October 2014. http://dx.doi.org/10.21236/ada624512.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Huang, Jiaguo, Ji Sun, Runmiao Hua, Yi Fan, and Chuan Guo. Prevalence of Sexual Dysfunction in Female Patients With Rheumatoid Arthritis: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2024. http://dx.doi.org/10.37766/inplasy2024.1.0016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zhang, Xiaolong, Zhirong Zhu, Guiliang Tang, and Huali Xu. Prevalence and risk factors of sexual dysfunction in females with type I diabetes: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2023. http://dx.doi.org/10.37766/inplasy2023.3.0054.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Li, Xiang, Shasha Liao, Caixia Liu, and Shuai Fu. Prevalence and Risk Factors for female sexual dysfunction in Individuals with postpartum depression: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2023. http://dx.doi.org/10.37766/inplasy2023.7.0119.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Duan, Liyang, Xiaoyu Li, Haiqin Rong, Haiju Sun, Yajun Zhang, Shipeng Song, Jianqiao Fang, and Yongqiang Sun. Scalp acupuncture for Post-stroke depression: A protocol for a systematic review and meta-analysis of randomized controlled clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0059.

Full text
Abstract:
Review question / Objective: To evaluate the efficacy and safety of scalp acupuncture for poststroke depression for the first time, and the results of this systematic review will be helpful for clinicians to use scalp acupuncture in the treatment of PSD. Condition being studied: Post-stroke depression (PSD) is one of the most common psychological sequelae of stroke, which is a state characterized by low mood and aversion to activity. It is one of the main obstacles in the process of stroke rehabilitation, which has a detrimental impact on functional recovery and quality of life and even increases mortality. Although the pathogenic factors of PSD are complex and diverse, it is now widely believed to involve complex interactions between neurobiological dysfunctions, psychosocial distress and biological factors. Despite increasing awareness and clinically based research on PSD, drugs to relieve and treat symptoms have made only limited gains. The use of antidepressants is accompanied by various unavoidable adverse effects, including headache, nausea, restlessness, and sexual dysfunction. A previous meta-analysis demonstrated that acupuncture can be safe and effective for the treatment of post-stroke depression. However, there is a lack of systematic reviews to evaluate the efficacy and safety of scalp acupuncture, which is a commonly used acupuncture modality in the treatment of PSD. Consequently, this study will assess the efficacy and safety of scalp acupuncture therapy for PSD compared to other treatments.
APA, Harvard, Vancouver, ISO, and other styles
8

Stone, Jay M. The Effects of False Physiological Feedback on Sexual Arousal in Sexually Dysfunctional and Functional Males. Fort Belvoir, VA: Defense Technical Information Center, January 1999. http://dx.doi.org/10.21236/ad1012248.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Galbreath, Nathan W. The Effects of False Physiological Feeback, on Sexual Arousal in Sexually Functional and Dysfunctional Men. Fort Belvoir, VA: Defense Technical Information Center, March 2004. http://dx.doi.org/10.21236/ad1014564.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rodolico, Alessandro, Valeria Meo, Carmen Concerto, Donatella Chiappetta, Marina Bonelli, Sebastiano Stuto, Ludovico Mineo, Maria Salvina Signorelli, and Eugenio Aguglia. Nutraceutical treatment for antidepressant induced sexual dysfunctions: a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2021. http://dx.doi.org/10.37766/inplasy2021.11.0051.

Full text
Abstract:
Review question / Objective: What are the effects of nutraceutical treatments for anti-depressant-induced sexual dysfunctions when added to standard care? Condition being studied: Anti-depressant induced sexual dysfunctions. Information sources We will search the following electronic databases: Web of Science, Embase, and PsycINFO, and CENTRAL (Cochrane Controlled Register of Trials).
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Sexual dysfunction' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography